WO2002095418A3 - Method of examining and diagnosing skin health - Google Patents

Method of examining and diagnosing skin health Download PDF

Info

Publication number
WO2002095418A3
WO2002095418A3 PCT/US2002/011344 US0211344W WO02095418A3 WO 2002095418 A3 WO2002095418 A3 WO 2002095418A3 US 0211344 W US0211344 W US 0211344W WO 02095418 A3 WO02095418 A3 WO 02095418A3
Authority
WO
WIPO (PCT)
Prior art keywords
examining
skin
subject
skin health
diagnosing skin
Prior art date
Application number
PCT/US2002/011344
Other languages
French (fr)
Other versions
WO2002095418A2 (en
Inventor
Gregory Skover
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/920,593 external-priority patent/US6840910B2/en
Priority claimed from US09/920,266 external-priority patent/US6790179B2/en
Priority claimed from US09/920,136 external-priority patent/US6855117B2/en
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Priority to CA002447323A priority Critical patent/CA2447323A1/en
Priority to EP02733970A priority patent/EP1412756A2/en
Publication of WO2002095418A2 publication Critical patent/WO2002095418A2/en
Publication of WO2002095418A3 publication Critical patent/WO2002095418A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • A—HUMAN NECESSITIES
    • A45—HAND OR TRAVELLING ARTICLES
    • A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D44/00—Other cosmetic or toiletry articles, e.g. for hairdressers' rooms
    • A45D2044/007—Devices for determining the condition of hair or skin or for selecting the appropriate cosmetic or hair treatment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors

Abstract

The present invention relates to a method of examining or diagnosing the skin health in a subject, the method including the steps of: accessing a sample of interstitial fluid from the skin of the subject; and measuring the amount of a skin analyte in the sample. The present invention also relates to a method of treating the skin of a subject and method of distributing a skin care product to a subject.
PCT/US2002/011344 2001-05-18 2002-04-05 Method of examining and diagnosing skin health WO2002095418A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002447323A CA2447323A1 (en) 2001-05-18 2002-04-05 Method of examining and diagnosing skin health
EP02733970A EP1412756A2 (en) 2001-05-18 2002-04-05 Method of examining and diagnosing skin health

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US09/920,136 2001-08-01
US09/920,266 2001-08-01
US09/920,593 US6840910B2 (en) 2001-08-01 2001-08-01 Method of distributing skin care products
US09/920,266 US6790179B2 (en) 2001-08-01 2001-08-01 Method of examining and diagnosing skin health
US09/920,593 2001-08-01
US09/920,136 US6855117B2 (en) 2001-08-01 2001-08-01 Method of treating the skin of a subject

Publications (2)

Publication Number Publication Date
WO2002095418A2 WO2002095418A2 (en) 2002-11-28
WO2002095418A3 true WO2002095418A3 (en) 2003-05-30

Family

ID=27420646

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/011344 WO2002095418A2 (en) 2001-05-18 2002-04-05 Method of examining and diagnosing skin health

Country Status (1)

Country Link
WO (1) WO2002095418A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010271259A (en) * 2009-05-25 2010-12-02 Sysmex Corp Method, device, cartridge and kit for analyzing biological component

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4313258A1 (en) * 1993-04-23 1994-10-27 Beiersdorf Ag Method and device for the quantitative measurement of the texture of the human skin surface by means of registration, reproduction and analysis of image information
US6027496A (en) * 1997-03-25 2000-02-22 Abbott Laboratories Removal of stratum corneum by means of light
WO2000010579A1 (en) * 1998-08-18 2000-03-02 California Skin Research Institute Method for detection of biological factors in epidermis
US6155992A (en) * 1997-12-02 2000-12-05 Abbott Laboratories Method and apparatus for obtaining interstitial fluid for diagnostic tests
JP2000352566A (en) * 1999-06-10 2000-12-19 Pola Chem Ind Inc Discrimination method of organism state
JP2001187025A (en) * 1999-10-22 2001-07-10 Kao Corp Method for evaluation of degree of health of skin
GB2358706A (en) * 1999-10-22 2001-08-01 Kao Corp An apparatus and method for evaluating skin health
DE10100127A1 (en) * 2001-01-03 2002-10-02 Henkel Kgaa Procedure for determining the homeostasis of the skin
WO2002082093A2 (en) * 2001-04-02 2002-10-17 Tufts University Methods to measure lipid antioxidant activity

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4313258A1 (en) * 1993-04-23 1994-10-27 Beiersdorf Ag Method and device for the quantitative measurement of the texture of the human skin surface by means of registration, reproduction and analysis of image information
US6027496A (en) * 1997-03-25 2000-02-22 Abbott Laboratories Removal of stratum corneum by means of light
US6155992A (en) * 1997-12-02 2000-12-05 Abbott Laboratories Method and apparatus for obtaining interstitial fluid for diagnostic tests
WO2000010579A1 (en) * 1998-08-18 2000-03-02 California Skin Research Institute Method for detection of biological factors in epidermis
JP2000352566A (en) * 1999-06-10 2000-12-19 Pola Chem Ind Inc Discrimination method of organism state
JP2001187025A (en) * 1999-10-22 2001-07-10 Kao Corp Method for evaluation of degree of health of skin
GB2358706A (en) * 1999-10-22 2001-08-01 Kao Corp An apparatus and method for evaluating skin health
DE10100127A1 (en) * 2001-01-03 2002-10-02 Henkel Kgaa Procedure for determining the homeostasis of the skin
WO2002082093A2 (en) * 2001-04-02 2002-10-17 Tufts University Methods to measure lipid antioxidant activity

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
K. BORK ET AL: "Histamine levels in interstitial fluid of lesioned and perilesional skin in patients with chronic idiopathic urticaria", ARCHIVES OF DERMATOLOGICAL RESEARCH, vol. 266, no. 3, 1979, pages 269 - 276, XP002230076 *
MAILE LAURA A ET AL: "Active and inhibitory components of the insulin-like growth factor binding protein-3 protease system in adult serum, interstitial, and synovial fluid.", ENDOCRINOLOGY, vol. 139, no. 12, December 1998 (1998-12-01), pages 4772 - 4781, XP002230077, ISSN: 0013-7227 *
PATENT ABSTRACTS OF JAPAN vol. 2000, no. 15 6 April 2001 (2001-04-06) *
PATENT ABSTRACTS OF JAPAN vol. 2000, no. 24 11 May 2001 (2001-05-11) *

Also Published As

Publication number Publication date
WO2002095418A2 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
WO2002040634A3 (en) Expression miniarrays and uses thereof
WO2004063713A3 (en) Non-invasive determination of direction and rate of change of an analyte
WO2003057838A3 (en) Antibodies against the muc18 antigen
WO2003007803A3 (en) Methods for diagnosing and treating alzheimer's disease and parkinson's disease
EP1260815A3 (en) Methods for automatically monitoring analyte concentration using minimally invasive devices
WO2003057837A3 (en) Methods for using anti-muc18 antibodies
WO2002010725A3 (en) Method for non-invasively determining the concentration of an analyte by compensating for the effect of tissue hydration
WO2005014035A3 (en) Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
EP1284121A3 (en) Physiological sample collection devices and methods of using the same
WO2004044557A3 (en) Non-invasive measurement of analytes
WO2002003857A3 (en) Method of tissue modulation for noninvasive measurement of an analyte
WO2003055443A3 (en) Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
WO2003024388A3 (en) Methods and compositions for treating and preventing skin disorders using binding agents specific for psma
AU7494701A (en) Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
CA2421007A1 (en) Method for detection of htr and htert telomerase-associated rna in plasma or serum
WO2002046222A3 (en) Compositions and methods for diagnosing alzheimer's disease
WO2003073910A3 (en) Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples
WO2004028341A3 (en) Susceptibility gene for human stroke; methods of treatment
WO2008014135A3 (en) Non-invasive analyte measurement glasses and method of use
EP1310797A3 (en) Method of monitoring neuroprotective treatment
WO2003016464A3 (en) Cancer specific oligosaccharide sequences and use thereof
WO2002095358A3 (en) System and method for monitoring or treating a health condition
WO2002041842A3 (en) Antibody pti-hs7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease
TR200202488T2 (en) Device and method for producing high-function water and water containing titanium
EP1130123A3 (en) Diagnostic method

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2447323

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002733970

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2002733970

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP